Literature DB >> 14704886

Self-rated emotional functioning of patients with neurological or asymptomatic form of Wilson's disease.

Joanna Seniów1, Barbara Mroziak, Anna Członkowska, Anna Jedryka-Góral.   

Abstract

Psychopathology was assessed in 50 patients with the neurological form of Wilson's disease (WD-N) and in 17 asymptomatic patients (WD-A) compared to matched healthy controls and to rheumatoid arthritis (RA) control patients using The Hopkins Symptom Checklist. As hypothesized, WD-N patients had significantly lower interpersonal sensitivity and aggression/hostility scores than had healthy controls, but did not differ from them either in depression or anxiety levels. Retarded depression and anxiety were higher among RA patients than in WD-N patients. This nondistressed response to the chronic disabling disease was even more salient in 19 WD patients with lesions in basal ganglia only. WD-A patients did not differ from their healthy peers, which suggests a tendency towards hypercompensation and denial in the former. WD-N patients' limited awareness of their deficits (including impaired control of affective behavior) seems to result from their brain damage implicating the basal ganglia.

Entities:  

Mesh:

Year:  2003        PMID: 14704886     DOI: 10.1076/clin.17.3.367.18085

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  8 in total

Review 1.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

Review 2.  Population screening and diagnostic strategies in screening family members of Wilson's disease patients.

Authors:  Huamei Li; Ran Tao; Lifang Liu; Shiqiang Shang
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

Review 4.  Wilson's disease: a comprehensive review of the molecular mechanisms.

Authors:  Fei Wu; Jing Wang; Chunwen Pu; Liang Qiao; Chunmeng Jiang
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

5.  Social cognition in Wilson's disease: A new phenotype?

Authors:  Elodie Peyroux; Nelly Santaella; Emmanuel Broussolle; Caroline Rigard; Emilie Favre; Anne-Sophie Brunet; Muriel Bost; Alain Lachaux; Caroline Demily
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

6.  Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta-Analysis.

Authors:  Shan Tang; Li Bai; Wei Hou; Zhongjie Hu; Xinyue Chen; Jing Zhao; Chen Liang; Wei Zhang; Zhongping Duan; Sujun Zheng
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

7.  Quality of Life in Wilson's Disease: A Systematic Literature Review.

Authors:  Chakrapani Balijepalli; Kevin Yan; Lakshmi Gullapalli; Stephane Barakat; Helene Chevrou-Severac; Eric Druyts
Journal:  J Health Econ Outcomes Res       Date:  2021-12-08

8.  Clinical significance of self-descriptive apathy assessment in patients with neurological form of Wilson's disease.

Authors:  Marcin Leśniak; Magdalena Roessler-Górecka; Anna Członkowska; Joanna Seniów
Journal:  Neurol Sci       Date:  2021-06-14       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.